KPL Relative Valuation - Kwality Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 1 306.35 INR -6.09% Market Closed

Market Cap: ₹13.6B

	Kwality Pharmaceuticals Ltd BSE:539997	IN
	PRA Group Inc NASDAQ:PRAA	US

Multiples-Based Value

539997 price has not been updated for more than 5 years. This may indicate that the stock has been delisted.

539997 doesn't have a meaningful market cap.

The Multiples-Based Value of one KPL stock under the Base Case scenario is 1 092.71 INR. Compared to the current market price of 1 306.35 INR, Kwality Pharmaceuticals Ltd is Overvalued by 16%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

KPL Multiples-Based Value

Base Case

Overvaluation 16%

Multiples-Based Value

Price ₹1 306.35

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
IN		Kwality Pharmaceuticals Ltd BSE:539997	13.6B INR	2.9	24	12.7	15.6
US		Eli Lilly and Co NYSE:LLY	837.7B USD	13.2	41.8	28.2	30.1
US		Johnson & Johnson NYSE:JNJ	583.9B USD	6.2	21.9	15.2	18.7
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.4	11.5	13
UK		AstraZeneca PLC LSE:AZN	228B GBP	5.2	29.9	16.5	23.3
US		Merck & Co Inc NYSE:MRK	292.3B USD	4.6	16.3	10.1	12.3
CH		Novartis AG SIX:NOVN	229.9B CHF	5.3	21.5	13.3	17.1
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
US		Pfizer Inc NYSE:PFE	157.9B USD	2.5	20.4	7.8	10.4
DK		Novo Nordisk A/S CSE:NOVO B	1T DKK	3.4	10.1	7.5	8.8
US		Bristol-Myers Squibb Co NYSE:BMY	120.2B USD	2.5	17.2	7.2	8.9

				Revenue Growth	P/S to Growth
IN		Kwality Pharmaceuticals Ltd BSE:539997	Average P/S: 13.8 2.9	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13.2	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	6%	1
CH		Roche Holding AG SIX:ROG	4.1	4%	1
UK		AstraZeneca PLC LSE:AZN	5.2	7%	0.7
US		Merck & Co Inc NYSE:MRK	4.6	5%	0.9
CH		Novartis AG SIX:NOVN	5.3	5%	1.1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	2%	1.7
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
IN		Kwality Pharmaceuticals Ltd BSE:539997	Average P/E: 22.2 24	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	41.8	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.9	7%	3.1
CH		Roche Holding AG SIX:ROG	19.4	14%	1.4
UK		AstraZeneca PLC LSE:AZN	29.9	26%	1.1
US		Merck & Co Inc NYSE:MRK	16.3	14%	1.2
CH		Novartis AG SIX:NOVN	21.5	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
US		Pfizer Inc NYSE:PFE	20.4	22%	0.9
DK		Novo Nordisk A/S CSE:NOVO B	10.1	1%	10.1
US		Bristol-Myers Squibb Co NYSE:BMY	17.2	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
IN		Kwality Pharmaceuticals Ltd BSE:539997	Average EV/EBITDA: 45.9 12.7	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	28.2	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15.2	2%	7.6
CH		Roche Holding AG SIX:ROG	11.5	6%	1.9
UK		AstraZeneca PLC LSE:AZN	16.5	13%	1.3
US		Merck & Co Inc NYSE:MRK	10.1	3%	3.4
CH		Novartis AG SIX:NOVN	13.3	5%	2.7
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	7.8	-9%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.5	1%	7.5
US		Bristol-Myers Squibb Co NYSE:BMY	7.2	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
IN		Kwality Pharmaceuticals Ltd BSE:539997	Average EV/EBIT: 99.9 15.6	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	30.1	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.7	6%	3.1
CH		Roche Holding AG SIX:ROG	13	6%	2.2
UK		AstraZeneca PLC LSE:AZN	23.3	21%	1.1
US		Merck & Co Inc NYSE:MRK	12.3	6%	2
CH		Novartis AG SIX:NOVN	17.1	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	10.4	-4%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	8.8	2%	4.4
US		Bristol-Myers Squibb Co NYSE:BMY	8.9	-7%	N/A

Kwality Pharmaceuticals Ltd
BSE:539997

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

KPL Competitors Multiples
Kwality Pharmaceuticals Ltd Competitors

See Also

Company

Help

Tools

Stocks

Kwality Pharmaceuticals Ltd BSE:539997

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

KPL Competitors Multiples Kwality Pharmaceuticals Ltd Competitors

See Also

Company

Help

Tools

Stocks

Kwality Pharmaceuticals Ltd
BSE:539997

KPL Competitors Multiples
Kwality Pharmaceuticals Ltd Competitors